Jubilant Pharma arm to raise USD 400 million loan from Standard Chartered Bank to repay debt

While the term loan and bonds aggregate to USD 350 million, about Rs 2,787 crore, the company is raising another tranche of USD 50 million (about Rs 400 crore) for capital expenditure.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bk6griF
via IFTTT